FOLH1 and neoplasm: To avoid experimental variations due to tumor differences, comparison of the uptake of [68 Ga]Ga-PSMA-1-DOTA to that of [68 Ga]Ga-PSMA-11 was performed in the same tumor-bearing animals after clearance of [68 Ga]Ga-PSMA-1-DOTA.